Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2023 06:03 ET | Source: Research and Markets

Global Cell Harvesting Strategic Market Report 2023-2030: Growing Use of Mesenchymal Stem Cells in Regenerative Medicine to Drive the Cell Harvesting Market

Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Cell Harvesting - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cell Harvesting Market to Reach...
April 14, 2023 11:13 ET | Source: Research and Markets

Cell Harvesting Global Market to Reach $483.3 Million by 2030: Development of Regenerative Medicine Accelerates Demand for Cell Harvesting

Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Cell Harvesting: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cell Harvesting...
April 07, 2022 06:53 ET | Source: Research and Markets

Global Cell Harvesting Market Research Report 2022-2026: With Stem Cells Holding Potential to Emerge as Savior for Healthcare System Struggling with COVID-19 Crisis, Demand for Cell Harvesting to Grow

Dublin, April 07, 2022 (GLOBE NEWSWIRE) -- The "Cell Harvesting - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Cell Harvesting Market...
August 03, 2021 05:28 ET | Source: Research and Markets

Insights on the Hematopoietic Stem Cell Transplantation Global Market to 2027 - Key Drivers, Restraints and Opportunities

Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Hematopoietic Stem Cell Transplantation (HSCT) Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to...
February 22, 2021 06:48 ET | Source: Research and Markets

Outlook on the Cell Therapy Biomanufacturing Global Market to 2025 - by Product Type, Application and Region

Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Biomanufacturing: Global Markets" report has been added to ResearchAndMarkets.com's offering. This research report presents an in-depth...
September 26, 2016 08:00 ET | Source: Fate Therapeutics, Inc.

Fate Therapeutics Receives FDA Orphan Drug Designation for ProTmune™ in Allogeneic Hematopoietic Cell Transplantation

SAN DIEGO, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...